Tulmimetostat (CPI-0209)
Selleck Chemicals
SKU:E1497-5MG
Couldn't load pickup availability

Tulmimetostat (CPI-0209) is an inhibitor of Androgen Receptor used in studies of Hormone Signaling. In practice, this places the compound in experiments that measure ligand-dependent transcriptional programs and endocrine regulation in cancer, endocrinology, and epigenetics models.
By inhibiting Androgen Receptor, Tulmimetostat (CPI-0209) can be used to examine ligand-dependent transcriptional programs and endocrine regulation. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In cancer, endocrinology, and epigenetics models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving Androgen Receptor
- Pathway perturbation studies connected to Hormone Signaling
- Concentration-response inhibition and target-dependence studies
- Reporter-gene, receptor-binding, and transcriptional assays
Overall, Tulmimetostat (CPI-0209) is appropriate when a defined chemical perturbant is needed to connect Androgen Receptor with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, endocrinology, and epigenetics models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- Androgen Receptor
- Target Class:
- Nuclear Receptor
- Pathways:
- Hormone Signaling
- Research Area:
- Cancer • Endocrinology • Epigenetics
- CAS No.:
- 2567686-02-4
- Molecular Weight:
- 562.12
- Formula:
- C₂₈H₃₆ClN₃O₅S
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.